HBM seeks expanded Basilea board

HBM BioVentures said Thursday it is seeking to add four independent directors to the five-member board of Basilea Pharmaceutica AG (SIX:BSLN). HBM, which is Basilea's largest shareholder with an 18% stake, proposed the nominees "to support the evaluation and implementation of strategic decisions and to unlock Basilea's untapped potential," according to a letter to the company. ...